Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Residence Characteristics | 4 | 2018 | 296 | 1.510 |
Why?
|
| Opioid-Related Disorders | 3 | 2023 | 414 | 1.130 |
Why?
|
| Environment Design | 2 | 2015 | 22 | 1.060 |
Why?
|
| Food Supply | 2 | 2015 | 63 | 1.010 |
Why?
|
| Social Environment | 2 | 2015 | 286 | 0.930 |
Why?
|
| Motor Activity | 2 | 2015 | 650 | 0.750 |
Why?
|
| Buprenorphine | 1 | 2023 | 134 | 0.730 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2017 | 2146 | 0.640 |
Why?
|
| Social Class | 1 | 2017 | 215 | 0.540 |
Why?
|
| Housing | 1 | 2016 | 118 | 0.530 |
Why?
|
| Health Transition | 1 | 2014 | 7 | 0.500 |
Why?
|
| Economic Development | 1 | 2014 | 3 | 0.500 |
Why?
|
| Atherosclerosis | 1 | 2017 | 341 | 0.460 |
Why?
|
| Body Mass Index | 3 | 2018 | 2058 | 0.430 |
Why?
|
| Group Processes | 1 | 2012 | 56 | 0.410 |
Why?
|
| Social Identification | 1 | 2012 | 49 | 0.410 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 954 | 0.400 |
Why?
|
| Blood Pressure | 2 | 2018 | 1633 | 0.380 |
Why?
|
| Overweight | 1 | 2014 | 481 | 0.370 |
Why?
|
| Patient Participation | 1 | 2013 | 366 | 0.340 |
Why?
|
| Education, Medical | 1 | 2012 | 230 | 0.340 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 683 | 0.330 |
Why?
|
| Students, Medical | 1 | 2012 | 288 | 0.310 |
Why?
|
| Medicaid | 2 | 2023 | 410 | 0.310 |
Why?
|
| Blood Glucose | 1 | 2016 | 1915 | 0.300 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 1113 | 0.300 |
Why?
|
| Smoking | 4 | 2018 | 1464 | 0.280 |
Why?
|
| Decision Making | 1 | 2013 | 809 | 0.270 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 1112 | 0.220 |
Why?
|
| Middle Aged | 9 | 2021 | 27140 | 0.200 |
Why?
|
| Obesity | 1 | 2014 | 2653 | 0.200 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 6478 | 0.200 |
Why?
|
| United States | 5 | 2023 | 12337 | 0.200 |
Why?
|
| Longitudinal Studies | 3 | 2018 | 2481 | 0.200 |
Why?
|
| Endocarditis, Bacterial | 1 | 2021 | 37 | 0.190 |
Why?
|
| Aged | 7 | 2021 | 19362 | 0.190 |
Why?
|
| Humans | 19 | 2023 | 116809 | 0.180 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2022 | 156 | 0.180 |
Why?
|
| Male | 12 | 2022 | 56636 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 4488 | 0.170 |
Why?
|
| Drug Overdose | 1 | 2023 | 291 | 0.170 |
Why?
|
| Economic Recession | 1 | 2018 | 5 | 0.170 |
Why?
|
| Risk Factors | 3 | 2017 | 8865 | 0.170 |
Why?
|
| Unemployment | 1 | 2018 | 42 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2020 | 205 | 0.160 |
Why?
|
| Argentina | 2 | 2014 | 14 | 0.150 |
Why?
|
| Female | 12 | 2022 | 60542 | 0.150 |
Why?
|
| Patient Care Team | 1 | 2021 | 511 | 0.140 |
Why?
|
| Alcohol Drinking | 2 | 2018 | 648 | 0.140 |
Why?
|
| Smoke-Free Policy | 1 | 2015 | 15 | 0.130 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2016 | 76 | 0.130 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 40 | 0.130 |
Why?
|
| Pandemics | 1 | 2023 | 1334 | 0.130 |
Why?
|
| Public Opinion | 1 | 2015 | 59 | 0.130 |
Why?
|
| China | 1 | 2015 | 173 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2017 | 6371 | 0.130 |
Why?
|
| Models, Psychological | 1 | 2016 | 299 | 0.130 |
Why?
|
| Behavior | 1 | 2015 | 94 | 0.130 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2014 | 29 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1248 | 0.120 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 231 | 0.110 |
Why?
|
| Mental Health | 1 | 2018 | 559 | 0.110 |
Why?
|
| Amnion | 1 | 2013 | 26 | 0.110 |
Why?
|
| Health Behavior | 1 | 2018 | 701 | 0.110 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2012 | 9 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2016 | 359 | 0.110 |
Why?
|
| Premature Birth | 2 | 2013 | 284 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2012 | 95 | 0.100 |
Why?
|
| Science | 1 | 2012 | 48 | 0.100 |
Why?
|
| Prevalence | 2 | 2016 | 2301 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2012 | 109 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 351 | 0.100 |
Why?
|
| Physician's Role | 1 | 2012 | 198 | 0.090 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 324 | 0.090 |
Why?
|
| Sex Factors | 1 | 2014 | 1749 | 0.080 |
Why?
|
| Incidence | 1 | 2015 | 2373 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2013 | 501 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 478 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2017 | 3016 | 0.080 |
Why?
|
| Communication | 1 | 2013 | 749 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 1784 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 10643 | 0.070 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 780 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2015 | 5047 | 0.060 |
Why?
|
| Minnesota | 1 | 2023 | 134 | 0.060 |
Why?
|
| Adolescent | 3 | 2018 | 18154 | 0.060 |
Why?
|
| Adult | 4 | 2021 | 30930 | 0.060 |
Why?
|
| Methadone | 1 | 2022 | 68 | 0.050 |
Why?
|
| Opiate Substitution Treatment | 1 | 2022 | 95 | 0.050 |
Why?
|
| Propensity Score | 1 | 2021 | 237 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 594 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 798 | 0.040 |
Why?
|
| Educational Status | 1 | 2018 | 433 | 0.030 |
Why?
|
| Mexico | 1 | 2015 | 162 | 0.030 |
Why?
|
| Lipids | 1 | 2018 | 584 | 0.030 |
Why?
|
| Receptors, Oxytocin | 1 | 2013 | 25 | 0.030 |
Why?
|
| Indians, South American | 1 | 2012 | 23 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1833 | 0.030 |
Why?
|
| CpG Islands | 1 | 2013 | 119 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 2013 | 53 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 179 | 0.030 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 231 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2013 | 99 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2013 | 5169 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2013 | 279 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 345 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 185 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 761 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2018 | 953 | 0.020 |
Why?
|
| Depression | 1 | 2018 | 1130 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 764 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 635 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 534 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1141 | 0.020 |
Why?
|
| Exercise | 1 | 2018 | 1613 | 0.020 |
Why?
|
| Fetus | 1 | 2012 | 689 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 1853 | 0.020 |
Why?
|
| Placenta | 1 | 2013 | 629 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1582 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2043 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 2232 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 4634 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 5650 | 0.010 |
Why?
|